(1) A pharmacist shall complete at least 30 CE hours which shall:
- (a) include 12 hours of live or technology-enabled participation in lectures, seminars, or workshops;
- (b) be relevant to the licensee's professional practice;
- (c) include one hour of pharmacy law or ethics;
- (d) if engaging in the administration of vaccines under Section R156-17b-621, include two hours in vaccine-related topics;
- (e) if engaging in the administration of prescription drugs or devices under Section R156-17b-621 or R156-17b-625, include two hours in topics related to the administration of those prescription drugs or devices; and
- (f) if dispensing a self-administered hormonal contraceptive in accordance with Title 26B, Chapter 4, Family Planning Access Act under Section R156-17b-621b, include two hours in topics related to hormonal contraceptive therapy.
(2)(a) A pharmacy technician shall complete at least 20 CE hours, which shall include:
(i) six hours of live or technology-enabled participation at lectures, seminars, or workshops;
- (ii) one hour of pharmacy law or ethics; and
- (iii) if engaging in the administration of vaccines under Section R156-17b-621, two hours in vaccine-related topics.
- (b) Current PTCB or ExCPT certification shall fulfill each CE requirements for a pharmacy technician, except for vaccine-related topic hours that may be required under Subsection (2)(a)(iii).
(3)(a) If a licensee first becomes licensed during the two-year renewal cycle, the licensee's required number of CE hours shall be decreased proportionately according to the date of licensure.
- (b) The Division may defer or waive each CE requirements as provided in Section R156-1-308d.
(4) CE credit shall be recognized as follows:
(a)(i) one live CE hour for attending one Board of Pharmacy meeting, up to a maximum of two CE hours during each two-year period; and
- (ii) these hours may count as "pharmacy law or ethics" hours;
(b)(i) two CE hours for each hour of lecturing or instructing a CE course or teaching in the licensee's profession, up to a maximum of ten CE hours during each two-year period;
- (ii) the licensee shall document the course's content and intended audience such as pharmacists, pharmacy technicians, pharmacy interns, physicians, or nurses; and
- (iii) public service programs, such as presentations to schoolchildren or service clubs, are not eligible for CE credit; and
(c) CE credit shall be approved by, conducted by, or under the sponsorship of one of the following:
- (i) institutes, seminars, lectures, conferences, workshops, various forms of mediated instruction, and programmed learning courses, presented by an ACPE-approved institution, individual, organization, association, corporation, or agency;
- (ii) programs approved by health-related CE approval organizations, if the CE is nationally recognized by a healthcare accrediting agency and is related to the practice of pharmacy;
- (iii) Division training or educational presentations;
- (iv) educational meetings that are ACPE accredited and are sponsored by the Utah Pharmacy Association, the Utah Society of Health-System Pharmacists, or other professional organization or association; or
- (v) for pharmacists, programs of certification by qualified individuals such as certified diabetes educator credentials, board certification, or other certification as approved by the Division in collaboration with the Board.
(5) A licensee shall maintain documentation sufficient to prove compliance with this section, for a period of four years after the end of the renewal cycle for which the CE is due, by:
- (a) maintaining registration with the NABP e-Profile CPE Monitor plan or the NABP CPE Monitor Plus plan; and
- (b) maintaining a certificate of completion or other adequate documentation for CE that cannot be tracked by the licensee's NABP plan.
Under Section 58-17b-310 and Subsections 58-1-203(1)(g) and 58-1-308(3)(b), this section establishes the continuing education (CE) requirements for renewal or reinstatement of a pharmacist or pharmacy technician license for each two-year renewal cycle.
KEY: pharmacists, licensing, pharmacies
Date of Last Change: August 8, 2025
Notice of Continuation: August 5, 2024
Authorizing, and Implemented or Interpreted Law: 63G-3-201; 58-17b-101; 58-17b-601(1); 58-37-1; 58-1-106(1)(a); 58-1-202(1)(a)